CLIO Cosmetics Co.,Ltd

Informe acción KOSDAQ:A237880

Capitalización de mercado: ₩314.7b

CLIO CosmeticsLtd Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de CLIO CosmeticsLtd de 11.8% y 11.9% por año respectivamente. Se prevé que el BPA crezca en un 11.4% al año. Se espera que la rentabilidad financiera sea de 15.8% en 3 años.

Información clave

11.8%

Tasa de crecimiento de los beneficios

11.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Personal Products10.0%
Tasa de crecimiento de los ingresos11.9%
Rentabilidad financiera futura15.8%
Cobertura de analistas

Good

Última actualización11 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With Earnings

Oct 08
CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Price Is Out Of Tune With Earnings

If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

Jun 26
If EPS Growth Is Important To You, CLIO CosmeticsLtd (KOSDAQ:237880) Presents An Opportunity

What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

May 25
What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

May 21
The Strong Earnings Posted By CLIO CosmeticsLtd (KOSDAQ:237880) Are A Good Indication Of The Strength Of The Business

We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Apr 24
We Like These Underlying Return On Capital Trends At CLIO CosmeticsLtd (KOSDAQ:237880)

Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) P/E Ratio

Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

Apr 13
Is CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 1.0% Dividend Worth Your Time?

When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Mar 30
When Should You Buy CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Mar 16
Here's Why CLIO CosmeticsLtd (KOSDAQ:237880) Can Manage Its Debt Responsibly

Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

Mar 02
Does This Valuation Of CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Imply Investors Are Overpaying?

CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Feb 17
CLIO CosmeticsLtd's (KOSDAQ:237880) Shareholders Are Down 47% On Their Shares

Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

Feb 02
Does CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Weak Fundamentals Mean That The Market Could Correct Its Share Price?

What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Jan 18
What Type Of Shareholders Make Up CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) Share Registry?

Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Jan 05
Are Dividend Investors Making A Mistake With CLIO Cosmetics Co.,Ltd (KOSDAQ:237880)?

Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Dec 23
Should You Think About Buying CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) Now?

Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 08
Are CLIO CosmeticsLtd's (KOSDAQ:237880) Statutory Earnings A Good Reflection Of Its Earnings Potential?

CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Nov 25
CLIO CosmeticsLtd (KOSDAQ:237880) Seems To Use Debt Rather Sparingly

Previsiones de crecimiento de beneficios e ingresos

KOSDAQ:A237880 - Estimaciones futuras de los analistas y datos financieros pasados (KRW Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/2026478,31745,88346,73356,1406
12/31/2025435,68641,32936,85047,2337
12/31/2024366,40028,90024,20031,7002
6/30/2024360,07035,97032,00032,625N/A
3/31/2024348,48932,16044,48045,288N/A
12/31/2023330,58427,69634,85635,725N/A
9/30/2023313,26424,21228,84929,841N/A
6/30/2023296,39417,55628,77329,877N/A
3/31/2023281,58815,03621,33022,356N/A
12/31/2022272,45510,129-1,41728,205N/A
9/30/2022259,4885,3094,23336,732N/A
6/30/2022250,9039,67335932,940N/A
3/31/2022240,7677,81515,09747,579N/A
12/31/2021232,7449,26748,29851,952N/A
9/30/2021223,55510,19537,28838,046N/A
6/30/2021214,7855,89337,63038,588N/A
3/31/2021208,3667,95011,85712,987N/A
12/31/2020218,2169,58510,52411,877N/A
9/30/2020237,5054,63014,45418,066N/A
6/30/2020249,1217,43614,09219,257N/A
3/31/2020260,3375,64347,15354,508N/A
12/31/2019250,3832,94228,02239,819N/A
9/30/2019230,1275,48259,24173,667N/A
6/30/2019214,24851750,47366,775N/A
3/31/2019199,73411922,54539,491N/A
12/31/2018187,37899648,26862,214N/A
9/30/2018186,9561,538-8,8171,843N/A
6/30/2018187,4424,151-2,6575,524N/A
3/31/2018181,8515,625N/A1,336N/A
12/31/2017193,6807,933N/A-22,989N/A
9/30/2017197,94313,777N/A-4,928N/A
6/30/2017201,32415,634N/A-1,244N/A
3/31/2017205,10716,339N/A-132N/A
12/31/2016193,59020,812N/A4,757N/A
9/30/2016177,60225,362N/A22,878N/A
6/30/2016164,51027,612N/A33,408N/A
3/31/2016136,41025,537N/A43,975N/A
12/31/2015107,07717,694N/A39,820N/A
12/31/201442,493608N/A-833N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (11.8% al año) de A237880 es superior a la tasa de ahorro (2.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (11.8% al año) de A237880 crezcan menos que el mercado KR (29.5% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de A237880 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (11.9% al año) de A237880 crezcan más rápidamente que los del mercado KR (9.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11.9% al año) de A237880 crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de A237880 sea baja dentro de 3 años (15.8%).


Descubre empresas en crecimiento